Recent research into Primary Sjögren's Syndrome (pSS) has focused on its genetic aspects. This chronic autoimmune disease is being studied to better understand its development and progression. By identifying key genes involved in the disease's pathogenesis, researchers can gain insights into potential therapeutic targets or diagnostic markers.
These findings are significant because they highlight specific genetic factors contributing to the disease. This work is crucial for advancing our understanding of pSS and could lead to more effective treatments or management strategies in the future. The study's approach could help uncover more about how these genes influence the disease's progression and how they can be targeted to improve patient outcomes (Wang et al., 2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: